XSPRAY.ST
Xspray Pharma AB (publ)
StockholmSEKEQUITY
Healthcare
DELAYED
Last price
10.46
▲ 0.06 (0.58%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
10.74
Prev close
10.40
Day high
10.74
Day low
10.20
Volume
139.78K
Market cap
$495.98M
P/E (TTM)
—
52W range
10.20 – 64.10
Day trading desk
Gap from prior close
+3.27%
Prior close 10.40
VWAP
10.43
+0.25% from price
Relative volume
2.12×
Unusually busy
Session range
5.29%
10.20 – 10.74
Position in range
48%
Mid range
ATR (14D)
1.10
10.54% of price
Prior day high
11.16
PDH
Prior day low
10.26
PDL
Bid / ask spread
—
Quote not published
Session volume
382.19K
Avg 179.98K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-23.65%
-22.3%
1M
-32.86%
-36.6%
3M
-56.60%
-59.7%
6M
-60.97%
-72.0%
YTD
-66.74%
-79.0%
1Y
-75.80%
-95.8%
3Y
-65.93%
-140.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on XSPRAY.ST open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
10.28M
Total on file
Fundamentals
Market cap$495.98M
Enterprise value$463.37M
Revenue (TTM)$2.47M
Gross profit$2.47M
EBITDA$-144.96M
Net income$-159.44M
EPS (TTM)$-3.81
Free cash flow$-122.39M
Total cash$179.90M
Total debt$147.30M
Book value / share$13.64
Shares outstanding47.42M
Float33.91M
Short % of float—
Dividend yield—
Beta (5Y)-0.03
Valuation & profitability ratios
Trailing P/E—
Forward P/E-6.58
PEG ratio—
Price / sales—
Price / book0.77
EV / revenue187.91
EV / EBITDA-3.20
Gross margin100.00%
Operating margin-464.62%
Profit margin0.00%
Return on equity-27.19%
Return on assets-12.20%
Debt / equity23.11
Current ratio1.39
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | — |
| Research & development | $10.75M | $79.36M | $40.26M | $22.22M | -86.5% |
| Selling, general & admin | $108.53M | $166.87M | $133.12M | $80.42M | -35.0% |
| Total operating expense | $159.13M | $283.24M | $180.76M | $131.38M | -43.8% |
| Operating income | -$159.13M | -$283.24M | -$180.76M | -$131.38M | +43.8% |
| Net interest income | -$14.64M | $1.37M | $2.05M | $1.40M | -1,169.9% |
| Pre-tax income | -$171.55M | -$285.67M | -$179.68M | -$131.67M | +40.0% |
| Tax provision | -$104.00K | -$151.00K | -$17.00K | $0 | +31.1% |
| Net income | -$171.44M | -$285.52M | -$179.67M | -$131.67M | +40.0% |
| Net income to common | -$171.44M | -$285.52M | -$179.67M | -$131.67M | +40.0% |
| Basic EPS | -4.34 | -8.38 | -6.46 | -5.90 | +48.3% |
| Diluted EPS | -4.34 | -8.38 | -6.46 | -5.90 | +48.3% |
| EBIT | -$154.69M | -$283.75M | -$179.01M | -$131.66M | +45.5% |
| EBITDA | -$149.12M | -$275.20M | -$169.81M | -$122.13M | +45.8% |
| Basic shares | 39.54M | 34.08M | 27.84M | 22.32M | +16.0% |
| Diluted shares | 39.54M | 34.08M | 27.84M | 22.32M | +16.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $153.75M | $208.24M | $166.30M | $120.17M | -26.2% |
| Cash & short-term investments | $153.75M | $208.24M | $166.30M | $120.17M | -26.2% |
| Accounts receivable | $3.84M | $4.02M | $4.17M | $2.36M | -4.4% |
| Inventory | $22.30M | $20.34M | $43.78M | $8.55M | +9.6% |
| Total current assets | $182.90M | $235.07M | $217.81M | $132.23M | -22.2% |
| Property, plant & equipment | $70.99M | $79.18M | $107.65M | $64.60M | -10.4% |
| Goodwill & intangibles | $512.19M | $478.93M | $436.78M | $385.60M | +6.9% |
| Total assets | $769.35M | $796.34M | $765.26M | $585.43M | -3.4% |
| Total current liabilities | $21.66M | $146.14M | $39.90M | $28.85M | -85.2% |
| Current debt | $0 | $96.00M | $0 | — | -100.0% |
| Long-term debt | $121.32M | $0 | — | — | — |
| Total debt | $148.39M | $128.22M | $36.81M | $2.13M | +15.7% |
| Total liabilities | $164.70M | $173.25M | $71.85M | $29.41M | -4.9% |
| Retained earnings | -$1.01B | -$840.25M | -$554.72M | -$375.06M | -20.4% |
| Shareholder equity | $604.65M | $623.10M | $693.41M | $556.02M | -3.0% |
| Working capital | $161.23M | $88.93M | $177.91M | $103.38M | +81.3% |
| Net tangible assets | $92.46M | $144.17M | $256.63M | $170.42M | -35.9% |
| Shares issued | 42.93M | 38.88M | 33.11M | 24.25M | +10.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$156.91M | -$287.04M | -$181.73M | -$133.07M | +45.3% |
| Depreciation & amortisation | $5.58M | $8.55M | $9.19M | $9.53M | -34.7% |
| Change in working capital | -$30.43M | $4.59M | -$31.58M | -$3.58M | -763.0% |
| Operating cash flow | -$193.16M | -$222.37M | -$203.28M | -$110.18M | +13.1% |
| Capital expenditure | -$29.19M | -$42.14M | -$54.10M | -$128.29M | +30.7% |
| Investing cash flow | -$29.19M | -$42.14M | -$65.88M | -$135.34M | +30.7% |
| Financing cash flow | $168.29M | $306.11M | $315.59M | $93.81M | -45.0% |
| Free cash flow | -$222.35M | -$264.51M | -$257.38M | -$238.47M | +15.9% |
| End cash position | $153.75M | $208.24M | $166.30M | $120.17M | -26.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | — | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | — | $0 | $0 | — |
| Research & development | $2.44M | $2.10M | $1.39M | — | $4.21M | $4.89M | +16.4% |
| Selling, general & admin | $24.72M | $30.01M | $20.51M | — | $27.05M | $36.03M | -17.6% |
| Total operating expense | $31.03M | $31.67M | $33.39M | — | $41.41M | $39.47M | -2.0% |
| Operating income | -$31.03M | -$31.67M | -$33.39M | — | -$41.41M | -$39.47M | +2.0% |
| Net interest income | -$8.77M | -$3.71M | -$3.62M | — | -$3.48M | -$2.86M | -136.2% |
| Pre-tax income | -$39.79M | -$35.38M | -$37.01M | — | -$44.88M | -$42.32M | -12.5% |
| Tax provision | -$14.00K | -$18.00K | -$21.00K | — | -$27.00K | -$31.00K | +22.2% |
| Net income | -$39.78M | -$35.36M | -$36.99M | — | -$44.86M | -$42.29M | -12.5% |
| Net income to common | -$39.78M | -$35.36M | -$36.99M | — | -$44.86M | -$42.29M | -12.5% |
| Basic EPS | -0.87 | -0.85 | -0.89 | -1.22 | -1.16 | — | -2.4% |
| Diluted EPS | -0.87 | -0.85 | -0.89 | -1.22 | -1.16 | — | -2.4% |
| EBIT | -$30.53M | -$31.15M | -$32.71M | — | -$41.10M | -$38.56M | +2.0% |
| EBITDA | -$29.49M | -$29.77M | -$31.32M | — | -$39.72M | -$37.15M | +0.9% |
| Basic shares | 45.81M | 41.74M | 41.74M | 38.82M | 38.88M | — | +9.8% |
| Diluted shares | 45.81M | 41.74M | 41.74M | 38.82M | 38.88M | — | +9.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $179.91M | $120.72M | $153.75M | — | $73.81M | $125.72M | +49.0% |
| Cash & short-term investments | $179.91M | $120.72M | $153.75M | — | $73.81M | $125.72M | +49.0% |
| Accounts receivable | $3.92M | $3.17M | $3.84M | — | $4.16M | $3.76M | +23.6% |
| Inventory | $19.55M | $22.93M | $22.30M | — | $35.12M | $30.01M | -14.7% |
| Total current assets | $215.11M | $149.92M | $182.90M | — | $116.85M | $162.72M | +43.5% |
| Property, plant & equipment | $67.26M | $68.95M | $70.99M | — | $75.07M | $77.11M | -2.4% |
| Goodwill & intangibles | $525.51M | $514.24M | $512.19M | — | $501.83M | $494.67M | +2.2% |
| Total assets | $811.18M | $736.39M | $769.35M | — | $696.98M | $737.71M | +10.2% |
| Total current liabilities | $154.62M | $146.64M | $21.66M | — | $137.09M | $131.47M | +5.4% |
| Current debt | $122.89M | $122.11M | $0 | — | $96.00M | $96.00M | +0.6% |
| Long-term debt | $0 | $0 | $121.32M | — | — | — | — |
| Total debt | $147.30M | $147.85M | $148.39M | — | $125.68M | $126.96M | -0.4% |
| Total liabilities | $173.68M | $167.03M | $164.70M | — | $161.53M | $157.25M | +4.0% |
| Retained earnings | -$1.09B | -$1.05B | -$1.01B | — | -$927.39M | -$882.54M | -3.8% |
| Shareholder equity | $637.50M | $569.36M | $604.65M | — | $535.45M | $580.46M | +12.0% |
| Working capital | $60.49M | $3.27M | $161.23M | — | -$20.24M | $31.25M | +1,748.1% |
| Net tangible assets | $111.99M | $55.12M | $92.46M | — | $33.62M | $85.79M | +103.2% |
| Shares issued | 47.42M | 41.74M | 42.93M | 42.93M | 38.88M | — | +13.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$31.03M | -$31.67M | -$33.39M | -$41.41M | -$39.47M | +2.0% |
| Depreciation & amortisation | $1.03M | $1.39M | $1.39M | $1.39M | $1.42M | -25.4% |
| Change in working capital | $1.82M | $3.35M | -$6.00M | -$3.73M | -$25.14M | -45.8% |
| Operating cash flow | -$36.95M | -$30.68M | -$41.37M | -$44.11M | -$66.33M | -20.4% |
| Capital expenditure | -$10.31M | -$1.07M | -$1.49M | -$6.13M | -$14.70M | -866.0% |
| Investing cash flow | -$10.31M | -$1.07M | -$1.49M | -$6.13M | -$14.70M | -866.0% |
| Financing cash flow | $106.49M | -$1.38M | -$1.32M | -$1.31M | -$1.39M | +7,822.3% |
| Free cash flow | -$47.25M | -$31.74M | -$42.86M | -$50.24M | -$81.03M | -48.9% |
| End cash position | $179.91M | $120.72M | $153.75M | $73.81M | $125.72M | +49.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Dec 2025 | 1.75 | -0.89 | -150.7% |
| Sep 2025 | -1.65 | -1.25 | +24.3% |
| Jun 2025 | -1.71 | -2.35 | -37.5% |
| Mar 2025 | -1.81 | -1.14 | +37.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $19.30M | 0.0% |
| Next year | 3.30 | 1 | $564.00M | +2,822.3% |
Analyst targets & ownership
Mean target$60.00
High target$60.00
Low target$60.00
Implied upside473.61%
Analyst count1
ConsensusNONE
Strong buy / Buy0 / 0
Hold0
Sell / Strong sell0 / 0
Held by insiders21.68%
Held by institutions40.89%
Institutions holding16
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
12.79
-18.20% from price
SMA 20
14.43
-27.51% from price
SMA 50
14.98
-30.19% from price
SMA 100
20.04
-47.79% from price
SMA 200
23.62
-55.72% from price
EMA 12
12.82
-18.39% from price
EMA 26
14.10
-25.80% from price
EMA 50
15.74
-33.52% from price
RSI (14)
21.4
Oversold
MACD (12,26,9)
-1.28
Hist -0.44
ATR (14)
1.10
10.54% of price
Realised vol 30D
85.4%
Annualised
Bollinger upper
18.48
20, 2σ
Bollinger lower
10.38
20, 2σ
50 / 200 cross
Death
14.98 vs 23.62
Trend bias
Below 200
-55.72%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.98
Less volatile than market
Correlation to SPY
0.14
Largely independent
Realised vol 30D
85.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-83.6%
Peak to trough
Max drawdown 5Y
-92.9%
Peak to trough
ATR 14
1.10
10.54% of price
Beta (reported)
-0.03
5Y monthly, from filing
Headlines
147 Laps Around the Mall: Washington Hosts Freedom 250 Street Race
The Wall Street Journal · 5m ago
BC-Nikkei 225 Futures
Associated Press · 6m ago
Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?
Insider Monkey · 8m ago
The Committee for a Responsible Federal Budget Estimates Social Security Cuts for Couples if the System Is Not Fixed
Motley Fool · 16m ago
Zoetis Earnings Reveal a Divided Business, But Can its Pipeline Restore Growth?
Insider Monkey · 17m ago
Liverpool striker Isak expected Newcastle abuse, says Iraola
AFP · 17m ago
Your mortgage rate has a growing problem in the bond market
TheStreet · 19m ago
Medtronic vs. Tenet Healthcare: Which Healthcare Stock Offers Better Long-Term Growth?
Insider Monkey · 23m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.